How and when should radiologists report T-staging on MRI in patients with prostate cancer?
BJU Int
.
2022 Oct;130(4):434-436.
doi: 10.1111/bju.15824.
Epub 2022 Jul 11.
Authors
Nikita Sushentsev
1
2
,
Tristan Barrett
1
2
,
Anne Y Warren
2
3
,
Vincent J Gnanapragasam
2
4
5
6
Affiliations
1
Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
2
Translational Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
3
Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
4
Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
5
Division of Urology, Department of Surgery, University of Cambridge, Cambridge, UK.
6
Cambridge Urology Translational Research and Clinical Trials Office, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, UK.
PMID:
35696280
DOI:
10.1111/bju.15824
No abstract available
Publication types
Letter
MeSH terms
Humans
Magnetic Resonance Imaging
Male
Neoplasm Staging
Prostatic Neoplasms* / diagnostic imaging
Prostatic Neoplasms* / pathology
Radiologists